Profusa shares rise 10.24% premarket after recapitalization cuts debt to $14M and achieves key 2026 revenue milestones.

Profusa Inc. surged 10.24% in premarket trading following the announcement of strategic recapitalization and operational milestones. The company reduced net debt from $34 million to $14 million by October 31, 2025, via a merger with NorthView Acquisition Corporation and $9 million in new financing. Key achievements included manufacturing build-out, European distributor partnerships covering 35% of the population, and a path to $0.5–$2 million in 2026 revenue. CEO Ben Hwang highlighted progress toward $200–$250 million in 2030 revenue, while CFO Fred Knechtel emphasized debt reduction and capital flexibility. The news reinforced confidence in Profusa’s ability to scale its Lumee oxygen monitoring platform and execute long-term growth strategies, directly aligning with the stock’s upward movement.